Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Bmi Placebo'

Bmi Placebo published presentations and documents on DocSlides.

The Bangkok Tenofovir Study

The Bangkok Tenofovir Study

  • marina-yarberry
  • 41 Slides

An HIV pre-exposure prophylaxis trial in Thailand...

STAT 250

STAT 250

  • conchita-marotz
  • 33 Slides

Dr. Kari Lock Morgan. Collecting Data: Randomized...

Have the OPTIMOX-2, CAIRO-3, COIN, DREAM and other recent t

Have the OPTIMOX-2, CAIRO-3, COIN, DREAM and other recent t

  • sherrill-nordquist
  • 23 Slides

Yes . Deborah . Schrag. , MD, MPH. No. John L. Ma...

MAT 1000

MAT 1000

  • pamella-moone
  • 38 Slides

Math. ematics. in . Today's . World. Last Time. ...

EDUCATIONAL SLIDE MODULES

EDUCATIONAL SLIDE MODULES

  • cheryl-pisano
  • 81 Slides

Module D: . Evaluating CV safety and potential fo...

Long-Term Tolerability of

Long-Term Tolerability of

  • briana-ranney
  • 16 Slides

Ticagrelor. for Secondary Prevention: . Insights...

Kenneth W. Mahaffey, MD,

Kenneth W. Mahaffey, MD,

  • myesha-ticknor
  • 17 Slides

on behalf of the TRACER Investigators and Committ...

Anthony Jones

Anthony Jones

  • lindy-dunigan
  • 56 Slides

Understanding the mechanisms in the development o...

Tranexamic acid, civilian trauma and the CRASH-2 trial

Tranexamic acid, civilian trauma and the CRASH-2 trial

  • sherrill-nordquist
  • 55 Slides

Ian Roberts. Tranexamic acid and bleeding. The ...

Chapter 13 part 2

Chapter 13 part 2

  • giovanna-bartolotta
  • 12 Slides

Observational Studies and Experiments. Experiment...

Mark Whitlock

Mark Whitlock

  • sherrill-nordquist
  • 16 Slides

Head of Statistics for Internal Medicine RU . Ear...

The Safety and Tolerability of CSL112, a Reconstituted, Inf

The Safety and Tolerability of CSL112, a Reconstituted, Inf

  • faustina-dinatale
  • 25 Slides

A. poA. -I . E. vent reducin. G. in . I. schemic...

Placebo + PR

Placebo + PR

  • aaron
  • 6 Slides

W24. DCV + PR. Placebo + PR. Yes. Dore GJ. Gastro...

Pravastatin in Elderly Individuals at Risk of Vascular Dise

Pravastatin in Elderly Individuals at Risk of Vascular Dise

  • min-jolicoeur
  • 5 Slides

Presented at Late Breaking Clinical Trials. AHA 2...

Comparison of Adherence among Partners’ PrEP Participants on Placebo before and after Release of

Comparison of Adherence among Partners’ PrEP Participants on Placebo before and after Release of

  • briana-ranney
  • 0 Slides

B. Wamuti. , J. Odoyo, B. Rono, C. Cohen, E. Buku...

New Drug Update 2016 A Formulary Approach

New Drug Update 2016 A Formulary Approach

  • test
  • 0 Slides

J. Russell May, Pharm.D., FASHP. Clinical Profess...

Dabigatran in myocardial injury after noncardiac

Dabigatran in myocardial injury after noncardiac

  • lois-ondreau
  • 0 Slides

surgery. Dr. PJ Devereaux on behalf of . MANAGE I...

Kenneth W. Mahaffey, MD,

Kenneth W. Mahaffey, MD,

  • cheryl-pisano
  • 0 Slides

on behalf of the TRACER Investigators and Committ...

1-Year outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery

1-Year outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery

  • mitsue-stanley
  • 0 Slides

Dr. PJ Devereaux on behalf of POISE. Investigato...

Presenters for Journal Club:

Presenters for Journal Club:

  • alida-meadow
  • 0 Slides

James Cooper. Eugenie . Shieh. Aaron . Schueneman...

Update on Treatment of Myasthenia Gravis

Update on Treatment of Myasthenia Gravis

  • conchita-marotz
  • 0 Slides

KUMC Neurology Grand Rounds. 07/29/2016. Richard...

How Do We Treat Obesity?

How Do We Treat Obesity?

  • liane-varnes
  • 0 Slides

Weight Loss Medications. 2. 3. Phentermine. 4. DE...

Planning for Retirement: Depression

Planning for Retirement: Depression

  • debby-jeon
  • 0 Slides

Richard C. Shelton, M.D.. James G. Blakemore Rese...

How Do We Treat Obesity?

How Do We Treat Obesity?

  • karlyn-bohler
  • 0 Slides

Weight Loss Medications. 2. 3. Phentermine. 4. DE...

Asthma: A Highly Prevalent and Often Inadequately Controlled Disease

Asthma: A Highly Prevalent and Often Inadequately Controlled Disease

  • lois-ondreau
  • 0 Slides

1. Centers for Disease Control and Prevention (CD...

UB Dept of Neurology UBMD Neurology/JNI

UB Dept of Neurology UBMD Neurology/JNI

  • alida-meadow
  • 0 Slides

brains. &GAINS. November 2, 2013. 9-12 a.m.. ...

CV safety & Outcome trials of

CV safety & Outcome trials of

  • aaron
  • 0 Slides

Oral . Antidiabetics. Adverse CV events led the F...

Trial Design Evolocumab SC

Trial Design Evolocumab SC

  • danika-pritchard
  • 0 Slides

140 mg Q2W or 420 mg QM. Placebo SC. Q2W or QM. L...

Apixaban vs VKA and

Apixaban vs VKA and

  • cheryl-pisano
  • 23 Slides

Apixaban vs VKA and Aspirin vs Placebo in Patie...

ETHICAL ASPECTS of

ETHICAL ASPECTS of

  • cheryl-pisano
  • 25 Slides

ETHICAL ASPECTS of PLACEBO SURGERY AAOS ETHICS ...

AMERICAN COLLEGE OF CARDIOLOGY SCIENTIFIC SESSIONS 2019

AMERICAN COLLEGE OF CARDIOLOGY SCIENTIFIC SESSIONS 2019

  • yoshiko-marsland
  • 30 Slides

AMERICAN COLLEGE OF CARDIOLOGY SCIENTIFIC SESSION...

PPAR  activation Clinical

PPAR  activation Clinical

  • maniakti
  • 18 Slides

evidence. Evolution of clinical evidence supportin...

Best of ASCO GU Session Sandy Srinivas.MD

Best of ASCO GU Session Sandy Srinivas.MD

  • experimentgoogle
  • 59 Slides

Stanford University. Outline. Abstract #4. :. . I...

Long -Term Efficacy of Dapagliflozin in T2DM Patients Receiving

Long -Term Efficacy of Dapagliflozin in T2DM Patients Receiving

  • vamput
  • 11 Slides

High-Dose Insulin. John . P.H. . Wilding, DM, FRCP...

Edward Fox, MD, PhD Phase 2 Multicenter Study Results of

Edward Fox, MD, PhD Phase 2 Multicenter Study Results of

  • medmacr
  • 17 Slides

Ublituximab. , a Novel Glycoengineered Anti-CD20 M...

Management of Dementia:

Management of Dementia:

  • maniakiali
  • 39 Slides

Pharmacologic and Non-Pharmacologic . Approaches. ...

EDUCATIONAL SLIDE MODULES

EDUCATIONAL SLIDE MODULES

  • dsuser1
  • 81 Slides

Module D: . Evaluating CV safety and potential for...

New Insights from EXSCEL

New Insights from EXSCEL

  • pongre
  • 22 Slides

M. Angelyn Bethel, MD. Associate Professor of Diab...

Submitter Name: Marta Ceko

Submitter Name: Marta Ceko

  • jasmine
  • 1 Slides

PI Name: Tor D. WagerPI email: tor.wager@colorado....

HIGHLIGHTSOFPRESCRIBINGINFORMATIONThesehighlightsdonotincludealltheinf

HIGHLIGHTSOFPRESCRIBINGINFORMATIONThesehighlightsdonotincludealltheinf

  • byrne
  • 13 Slides

Notforthereliefofacutebronchospasmorstatusasthmati...

Copyright © 2024 DocSlides. All Rights Reserved